Article

Spatial Transcriptomic Signature of Progressive Fibrosis in Human MASLD: Role of…

medRxiv · 2025 · Vu, H.; Sun, Y.; Xiong, Z.; Radford-Smith, D. E.; Causer, A.; Nefzger, C.; O'Sullivan, E.; Watt, M. J.; Ramm, G.; Clouston, A.; Irvine, K.; Nguyen, Q.; Powell, E.

Key facts

Title Spatial Transcriptomic Signature of Progressive Fibrosis in Human MASLD: Role of Senescence and Metabolic Reprogramming.
First author Vu, H.; Sun, Y.; Xiong, Z.; Radford-Smith, D. E.; Causer, A.; Nefzger, C.; O'Sullivan, E.; Watt, M. J.; Ramm, G.; Clouston, A.; Irvine, K.; Nguyen, Q.; Powell, E.
Journal medRxiv
Published Jan 1, 2025
DOI 10.1101/2025.03.20.644239
Product codes mentioned KPA, NJT, PFF, PFT, PPM

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature